Evidence map›Paper›PMID 30921707›Full record

ReviewCurrent opinion in structural biology2019

Insights into the mechanism and pharmacology of neurotransmitter sodium symporters.

Vikas Navratna, Eric Gouaux

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in structural biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Cytosolic KJournal of chemical theory and computation · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vikas NavratnaVollum Institute, Oregon Health & Science University, Portland, OR, United States.
Eric GouauxVollum Institute, Oregon Health & Science University, Portland, OR, United States; Howard Hughes Medical Institute, Oregon Health & Science University, Portland, OR, United States. Electronic address: gouauxe@ohsu.edu.
Oregon Health & Science University · US

Funding

Structure and Function of Neurotransmitter TransportersR01MH070039 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 2004 to 2024
$4.1M
Structure and Function of Neurotransmitter TransportersR37MH070039 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 2009 to 2018
$3.8M
Howard Hughes Medical InstituteNIMH NIH HHS R01 MH070039NIMH NIH HHS R37 MH070039
6 · The paper itself

Abstract

Neurotransmitter sodium symporters (NSS) belong to the SLC6 family of solute carriers and play an essential role in neurotransmitter homeostasis throughout the body. In the past decade, structural studies employing bacterial orthologs of NSSs have provided insight into the mechanism of neurotransmitter transport. While the overall architecture of SLC6 transporters is conserved among species, in comparison to the bacterial homologs, the eukaryotic SLC6 family members harbor differences in amino acid sequence and molecular structure, which underpins their functional and pharmacological diversity, as well as their ligand specificity. Here, we review the structures and mechanisms of eukaryotic NSSs, focusing on the molecular basis for ligand recognition and on transport mechanism.

Indexed as

AnimalsBinding SitesConserved SequenceHumansMolecular Targeted TherapyPharmacologyPlasma Membrane Neurotransmitter Transport ProteinsPlasma Membrane Neurotransmitter Transport Proteins

Identifiers

PMID30921707
PMCPMC6592764
OpenAlexW2923284820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.